Net Product Revenues - Summary (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Net product revenues
Disaggregation of Revenue [Line Items]
Total Net Product Revenues	$ 4,605	$ 0	$ 11,131	$ 0
Wynzora
Disaggregation of Revenue [Line Items]
Total Net Product Revenues	411		1,061
Rhofade
Disaggregation of Revenue [Line Items]
Total Net Product Revenues	3,475		8,566
Minolira
Disaggregation of Revenue [Line Items]
Total Net Product Revenues	374		764
Cloderm
Disaggregation of Revenue [Line Items]
Total Net Product Revenues	148		387
Other
Disaggregation of Revenue [Line Items]
Total Net Product Revenues	$ 197		$ 353
Product concentration risk | Net product revenues | Revenue benchmark
Disaggregation of Revenue [Line Items]
Percentage of Net Product Revenues	100.00%		100.00%
Product concentration risk | Wynzora | Revenue benchmark
Disaggregation of Revenue [Line Items]
Percentage of Net Product Revenues	8.90%		9.50%
Product concentration risk | Rhofade | Revenue benchmark
Disaggregation of Revenue [Line Items]
Percentage of Net Product Revenues	75.50%		77.00%
Product concentration risk | Minolira | Revenue benchmark
Disaggregation of Revenue [Line Items]
Percentage of Net Product Revenues	8.10%		6.90%
Product concentration risk | Cloderm | Revenue benchmark
Disaggregation of Revenue [Line Items]
Percentage of Net Product Revenues	3.20%		3.50%
Product concentration risk | Other | Revenue benchmark
Disaggregation of Revenue [Line Items]
Percentage of Net Product Revenues	4.30%		3.20%